122 related articles for article (PubMed ID: 36749246)
1. Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study.
Paksoy N; Khanmammadov N; Doğan İ; Ferhatoğlu F; Ahmed MA; Karaman S; Aydiner A
Medicine (Baltimore); 2023 Feb; 102(5):e32866. PubMed ID: 36749246
[TBL] [Abstract][Full Text] [Related]
2. Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.
Di Lorenzo G; Di Trolio R; Montesarchio V; Palmieri G; Nappa P; Delfino M; De Placido S; Dezube BJ
Cancer; 2008 Mar; 112(5):1147-52. PubMed ID: 18098221
[TBL] [Abstract][Full Text] [Related]
3. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes of patients with classic and AIDS-related Kaposi Sarcoma: a single-center real-world experience.
Valcarcel-Valdivia B; Enriquez-Vera D; Piedra LE; Holguín A; De la Cruz Ku G
Clin Exp Med; 2023 Dec; 23(8):5463-5471. PubMed ID: 37940724
[TBL] [Abstract][Full Text] [Related]
6. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS).
Tas F; Sen F; Keskin S; Kilic L
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):789-92. PubMed ID: 22188463
[TBL] [Abstract][Full Text] [Related]
7. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
8. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
Lim ST; Tupule A; Espina BM; Levine AM
Cancer; 2005 Jan; 103(2):417-21. PubMed ID: 15578686
[TBL] [Abstract][Full Text] [Related]
9. Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).
Zer A; Icht O; Yosef L; Avram D; Jacobi O; Fenig E; Kurman N; Peretz I; Shamai S; Merimsky O; Ben-Ami E; Shapira Frommer R; Schwarzbach AE; Bernstine H; Weitzen R; Vornicova O; Bar-Sela G; Stemmer SM; Lotem M
Ann Oncol; 2022 Jul; 33(7):720-727. PubMed ID: 35339649
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data.
Oyucu Orhan S; Bilgehan Sahin A; Cubukcu E; Deligonul A; Ocak B; Orhan B; Evrensel T
Bosn J Basic Med Sci; 2021 Dec; 21(6):746-751. PubMed ID: 33596402
[TBL] [Abstract][Full Text] [Related]
11. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
Fardet L; Stoebner PE; Bachelez H; Descamps V; Kerob D; Meunier L; Dandurand M; Morel P; Lebbe C
Cancer; 2006 Apr; 106(8):1785-9. PubMed ID: 16534786
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of paclitaxel in the treatment of Kaposi sarcoma.
Ercolak V; Sahin B; Gunaldi M; Duman BB; Afsar CU
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4095-100. PubMed ID: 26592833
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
[TBL] [Abstract][Full Text] [Related]
14. Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.
Park JH; Lee JL
Cancer Chemother Pharmacol; 2015 Feb; 75(2):247-54. PubMed ID: 25428517
[TBL] [Abstract][Full Text] [Related]
15. Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
Feliu J; Martin G; Lizón J; Chacón JI; Dorta J; de Castro J; Rodríguez A; Sánchez Heras B; Torrego JC; Espinosa E; González Barón M;
Ann Oncol; 2001 Oct; 12(10):1369-74. PubMed ID: 11762806
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S; Scambia G; Katsaros D; Gallo C; Pujade-Lauraine E; De Placido S; Bologna A; Weber B; Raspagliesi F; Panici PB; Cormio G; Sorio R; Cavazzini MG; Ferrandina G; Breda E; Murgia V; Sacco C; Cinieri S; Salutari V; Ricci C; Pisano C; Greggi S; Lauria R; Lorusso D; Marchetti C; Selvaggi L; Signoriello S; Piccirillo MC; Di Maio M; Perrone F; ; ; ; ;
Lancet Oncol; 2014 Apr; 15(4):396-405. PubMed ID: 24582486
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel as first- or second-line treatment for HIV-negative Kaposi's sarcoma: a retrospective study of 58 patients.
Tourlaki A; Germiniasi F; Rossi LC; Veraldi S; Brambilla L
J Dermatolog Treat; 2020 Mar; 31(2):183-185. PubMed ID: 30897011
[No Abstract] [Full Text] [Related]
18. Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.
Borghaei H; Millenson M; Schilder R; Alden M; Rogatko A; Wang H; Padavic-Shaller K; Smith MR
Cancer; 2004 Nov; 101(9):2034-41. PubMed ID: 15455357
[TBL] [Abstract][Full Text] [Related]
19. Salvage weekly paclitaxel in recurrent ovarian cancer.
Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
[TBL] [Abstract][Full Text] [Related]
20. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
Shitara K; Takashima A; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Makari Y; Amagai K; Ueda S; Yoshida K; Shimodaira H; Nishina T; Tsuda M; Kurokawa Y; Tamura T; Sasaki Y; Morita S; Koizumi W
Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
